Novabay Pharmaceuticals Inc Retorno sobre activos
¿Qué es el Retorno sobre activos de Novabay Pharmaceuticals Inc?
El Retorno sobre activos de Novabay Pharmaceuticals Inc es -136.86%
¿Cuál es la definición de Retorno sobre activos?
El rendimiento de los activos indica cuál rentables son los activos de una empresa para generar ingresos. Se calcula dividiendo la utilidad neta por el promedio de los activos totales.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Retorno sobre activos de compañías en Sector Health Care en NYSEMKT en comparadas con Novabay Pharmaceuticals Inc
¿Qué hace Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Empresas con retorno sobre activos similar a Novabay Pharmaceuticals Inc
- China International Investments tiene Retorno sobre activos de -137.76%
- Libero Copper & Gold tiene Retorno sobre activos de -137.48%
- SenesTech Inc tiene Retorno sobre activos de -137.32%
- Eyenovia Inc tiene Retorno sobre activos de -137.04%
- Monarca Minerals tiene Retorno sobre activos de -137.01%
- Venture Minerals tiene Retorno sobre activos de -136.89%
- Novabay Pharmaceuticals Inc tiene Retorno sobre activos de -136.86%
- Cabral Gold tiene Retorno sobre activos de -136.71%
- Technical Communications tiene Retorno sobre activos de -136.68%
- Forward Water Technologies tiene Retorno sobre activos de -136.61%
- Minerva Intelligence tiene Retorno sobre activos de -136.32%
- 102570 tiene Retorno sobre activos de -136.31%
- Next Dynamics Inc tiene Retorno sobre activos de -135.98%